Taro Pharmaceutical Industries Ltd.

The momentum for this stock is not very good. Taro Pharmaceutical Industries Ltd. has good growth characteristics. Taro Pharmaceutical Industries Ltd. is not very popular among insiders. Taro Pharmaceutical Industries Ltd. is a mediocre stock to choose.
Log in to see more information.
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of pres...

News

TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Globe Newswire NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been...\n more…

Ademi LLP announces the filing of Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and other Defendants
Ademi LLP announces the filing of Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and other Defendants

PR Newswire Ademi LLP announces the filing of Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and other Defendants Ademi LLP announces the filing of Class Action Lawsuit against Taro...\n more…

Sun Pharma Completes Taro Merger
Sun Pharma Completes Taro Merger

PR Newswire Sun Pharma Completes Taro Merger Sun Pharma Completes Taro Merger PR Newswire MUMBAI, India and PRINCETON, N.J., June 24, 2024 Combined entity is better positioned to compete in increasingly...\n more…

Taro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated at StockNews.com
Taro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated at StockNews.com

Ticker Report Equities researchers at StockNews.com began coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO - Get Free Report) in a report issued on Saturday. The brokerage set a "strong-buy" rating...\n more…

Dimensional Fund Advisors LP Has $22.80 Million Position in Taro Pharmaceutical Industries Ltd. (NYSE:TARO)
Dimensional Fund Advisors LP Has $22.80 Million Position in Taro Pharmaceutical Industries Ltd. (NYSE:TARO)

Zolmax Dimensional Fund Advisors LP reduced its stake in Taro Pharmaceutical Industries Ltd. (NYSE:TARO - Free Report) by 0.8% during the 4th quarter, according to the company in its most recent disclosure...\n more…

StockNews.com Begins Coverage on Taro Pharmaceutical Industries (NYSE:TARO)
StockNews.com Begins Coverage on Taro Pharmaceutical Industries (NYSE:TARO)

Zolmax StockNews.com began coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO - Free Report) in a research report report published on Wednesday. The firm issued a strong-buy rating on the...\n more…